Cognition following bilateral implants of embryonic dopamine neurons in PD: A double blind study

Neurology

Volumn 60, Issue 12, 2003, Pages 1938-1943

  Trott, C T ^a   Fahn, S ^b   Greene, P ^b   Dillon, S ^b   Winfield, H ^b   Winfield, L ^b   Kao, R ^b   Eidelberg, D ^c   Freed, C R ^d   Breeze, R E ^d   Stern, Yaakov ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^d UNIVERSITY OF COLORADO HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; ATTENTION; BRAIN FUNCTION; CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DEPTH PERCEPTION; DOPAMINERGIC NERVE CELL; DOUBLE BLIND PROCEDURE; EMBRYO CELL; FEMALE; HUMAN; LANGUAGE; MALE; MESENCEPHALON; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; ORIENTATION; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERBAL MEMORY; VISUAL MEMORY;

EID: 10744225925     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000070181.28651.3B     Document Type: Article

References (38)

1. Widner H, Tetrud J, Rehncrona S, et al. Fifteen months follow-up on bilateral embryonic mesencephalic grafts in two cases of severe MPTPinduced parkinsonism. In: Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y, eds. Advances in Neurology, vol. 60. New York: Raven Press, 1993:729-733.
2. Hauser RA, Freeman TB, Snow BJ, et al. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol 1999;56:179-187.
3. Sass KJ, Buchanan CP, Westerveld M, et al. General cognitive ability following unilateral and bilateral fetal ventral mesencephalic tissue transplantation for treatment of Parkinson's disease. Arch Neurol 1995; 52:680-686.
4. Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001; 344:710-719.
5. Folstein MF, Folstein SE, McHugh PR. "Mini-mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
6. Freed CR, Breeze RE, Greene PE, et al. Double-blind controlled trial of human embryonic dopamine cell transplants in advanced Parkinson's disease: study design, surgical strategy, patient demographics and pathological outcome. Neurology 1999;52(suppl 2):A272-A273. Abstract.
7. Stern Y, Andrews H, Pittman J, et al. Diagnosis of dementia in a heterogeneous population: development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol 1992;49:453-460.
8. Blair JR, Spreen O. Predicting premorbid IQ: a revision of the National Adult Reading Test. Clin Neuropsychol 1989;3:129-136.
9. Sano M, Rosen W, Mayeux R. Attention deficits in Alzheimer's disease. Washington, DC: American Psychiatric Association, 1984.
10. Benton AL. The Visual Retention Test. New York: The Psychological Corporation, 1955.
11. Sivan AB, Spreen O. Der Benton-Test, 7th ed. Berne, Switzerland: Verlag Hans Huber, 1906.
12. Rosen W. The Rosen Drawing Test. Bronx, NY: Veterans Administration Medical Center, 1981.
13. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York: The Psychological Corporation, 1981.
14. Salthouse TA. The role of processing resources in cognitive aging. In: Howe ML, Brainerd CJ, eds. Cognitive development in adulthood. New York: Springer-Verlag, 1988:185-239.
15. Bushke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974;24:1019-1025.
16. Delis DC, Massman PJ, Kaplan E, McKee R, Kramer JH, Gettman D. Alternate form of the California Verbal Learning Test: development and reliability. Clin Neuropsychol 1991;5:154-162.
17. Goodglass H, Kaplan E. The assessment of aphasia and related disorders, 2nd ed. Philadelphia: Lea & Febiger, 1983.
18. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea & Febiger, 1983.
19. Benton AL, Hamsher K. Multilingual Aphasia Examination. Iowa City, IA: AJA Associates, 1989.
20. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasu TB, eds. Geriatric psychiatry. New York: Grune & Stratton, 1976:77-121.
21. Flowers K, Robertson C. The effect of Parkinson's disease on the ability to maintain a mental set. J Neurol Neurosurg Psychiatry 1985;48:517-529.
22. Heaton RK. Wisconsin Card Sorting Test manual. Odessa, FL: Psychological Assessment Resources, 1981.
23. Fahn S, Elton RL, UPDRS Development Committee. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Healthcare Information, 1987;2:153-163, 293-304.
24. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2-13.
25. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
26. Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson IML, eds. Third symposium on Parkinson's disease. Edinburgh, Scotland: Livingstone, 1969:152-157.
27. Hamilton M. Rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-61.
28. Lindvall O, Rehncrona S, Brundin P, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. Arch Neurol 1989;46:615-631.
29. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991;114:2095-2122.
30. Middleton FA, Strick PL. Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies. Brain Cogn 2000;42: 183-200.
31. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N Engl J Med 1988;318:876-880.
32. Kulisevsky J. Role of dopamine in learning and memory. Implications for the treatment of cognitive dysfunction in patients with Parkinson's disease. Drugs Aging 2000;16:365-379.
33. Dubois B, Ruberg M, Javoy-Agid F, Ploska A, Agid Y. A subcorticocortical cholinergir system is affected in Parkinson's disease. Brain Res 1983;288:213-218.
34. Stern Y, Mayeux R, Cote L. Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism. Arch Neurol 1984;41:1086-1089.
35. Bedard MA, Pillon B, Dubois B, Duchesne N, Masson H, Agid Y. Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome. Brain Cogn 1999;40:289-313.
36. Cooper JA, Sagar HJ, Doherty SM, Jordan N, Tidswell P, Sullivan EV. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. Brain 1992;115:1701-1725.
37. Dubois B, Pillon B, Lhermitte F, Agid Y. Cholinergic deficiency and frontal dysfunction in Parkinson's disease. Ann Neurol 1990;28:117-121.
38. Levin ED, McGurk SR, Rose JE, Butcher LL. Cholinergic-dopaminergic interactions in cognitive performance. Behav Neural Biol 1990;54:271-299.